Clinical Trial Update: Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial evaluating the CARTO XP EP Navigation System v9 and SOUNDSTAR 3D Diagnostic Ultrasound for cardiac arrhythmias has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmias

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Cardiac Arrhythmias | Phase 2 | Status: WITHDRAWN